Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Titel:
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Auteur:
Zelenetz, Andrew D Barrientos, Jacqueline C Brown, Jennifer R Coiffier, Bertrand Delgado, Julio Egyed, Miklós Ghia, Paolo Illés, Árpád Jurczak, Wojciech Marlton, Paula Montillo, Marco Morschhauser, Franck Pristupa, Alexander S Robak, Tadeusz Sharman, Jeff P Simpson, David Smolej, Lukáš Tausch, Eugen Adewoye, Adeboye H Dreiling, Lyndah K Kim, Yeonhee Stilgenbauer, Stephan Hillmen, Peter